6 Russell Place Melbourne
19th July 2017 , 12:30pm - 2:00pm
$77.00 (inc. GST)
Bookings Close: 17th July 2017
Genomics is already having a huge impact on our ability to diagnose and understand of a range of disorders, and to target therapies to the individual. However, effective integration of this 'disruptive technology' into everyday clinical practice will require a 'whole-of-system' approach that builds on existing expertise. In Australia, we also need to overcome the 'state/federal divide' in the funding of genetic testing to develop a cohesive national approach that is cost effective and provides equitable access.
The Australian Genomics Health Alliance (AGHA) is an NHMRC-funded national collaborative network committed to implementing genomic medicine within Australia and providing evidence to inform policy and practice. AGHA comprises over 50 partner organisations including the diagnostic pathology and clinical genetics services of all Australian States and Territories, along with the major research and academic institutions and peak professional bodies. By approaching clinical genomics at a national rather than state-based level, we increase our critical mass and offer a single point of contact for government and for national and international consortia. Our approach – starting with the patient and developing a system that is focussed on improving patient care and outcomes – provides us with a unique opportunity to lead internationally in the integration of genomics into healthcare.
AGHA is also a leading member of the Global Alliance for Genomics and Health (GA4GH), an organisation of over 470 of the world’s leading biomedical research institutions, healthcare providers, information technology and life science companies, funders of research, and disease and patient advocacy organizations. The Global Alliance aims to accelerate the world-wide effort to responsibly aggregate, analyse and share large amounts of genomic and clinical information to advance the understanding, diagnosis, and treatment for cancer, inherited diseases, infectious diseases, and drug responses.
Professor Kathryn North AM is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne.
Professor North is trained as a paediatric physician, neurologist and clinical geneticist. In 1994 she was awarded a doctorate for research in Neurogenetics. She has also completed a post-doctoral fellowship in the Harvard Genetics Program. Her current laboratory research interests focus on the molecular basis of inherited muscle disorders and the genetic basis of elite athletic performance.